Evidence map›Paper›PMID 33348337›Full record

ArticleMedical principles and practice : international journal of the Kuwait University, Health Science Centre2021

Plasma Levels of Alpha and Gamma Synucleins in Autism Spectrum Disorder: An Indicator of Severity.

Sarah Al-Mazidi, Laila Y Al-Ayadhi

Open access · diamondAbstract read
In one paragraph

Article in Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Qualitative Evaluation of α-Synuclein: A Critical Step in Unravelling the Complexities of Autism Spectrum Disorder.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2023
    Article
  12. Reply to: "Qualitative Evaluation of α-Synuclein: A Critical Step in Unravelling the Complexities of Autism Spectrum Disorder".Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2023
    Article
  13. Article
  14. Review
  15. Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?International journal of molecular sciences · 2022
    Review
  16. Article
  17. Reply to "Plasma Levels of Alpha and Gamma Synucleins in Children with Autism Spectrum Disorder: Statistical Validity".Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2022
    Article
  18. Plasma Levels of Alpha and Gamma Synucleins in Children with Autism Spectrum Disorder: Statistical Validity.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2022
    Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sarah Al-MazidiDepartment of Physiology, Faculty of Medicine, Imam Mohammed bin Saud Islamic University, Riyadh, Saudi Arabia, s.almazeedi@gmail.com.
Laila Y Al-AyadhiAutism Research & Treatment Center, Al-Amodi Autism Research Chair, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.
Imam Mohammad ibn Saud Islamic University · SAKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to correlate plasma levels of the synaptic proteins α-synuclein and γ-synuclein in autism spectrum disorder (ASD) children in order to elucidate their possible contribution to the pathogenesis of ASD and to study their association with the severity of the disorder. SUBJECTS AND

methodsPlasma levels of α-synuclein and γ-synuclein were measured in 38 male children diagnosed with ASD and 40 healthy age-matched male children by ELISA.

resultsOur results showed that plasma levels of α-synuclein (18.02 ± 5.3 pg/mL) were significantly higher in ASD children than in control children (14.39 ± 2 pg/mL), and plasma levels of γ-synuclein were decreased in the ASD group (23.74 ± 7.7 pg/mL) compared to the control group (32.40 ± 6.8 pg/mL) (p < 0.0001). Our data also indicate that plasma levels of both α-synuclein and γ-synuclein are significantly associated with the severity of ASD.

conclusionsOur study showed that alteration in α-synuclein and γ-synuclein might be associated with ASD pathogenesis and could be an indicator of the severity of the disorder.

Indexed as

Severity of Illness Indexalpha-SynucleinAutism Spectrum DisorderChildChild, Preschoolgamma-SynucleinHumansMalealpha-Synucleingamma-SynucleinAutism spectrum disorderNeurologyPhysiologyPsychiatry

Identifiers

PMID33348337
PMCPMC8114064
OpenAlexW3115200139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.